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Original article
Should Younger Siblings of   Peanut-  Allergic Children Be 
Assessed by an Allergist before Being Fed Peanut?
Joel J. Liem, MD, FRCPC, Saiful Huq, BSc, Anita L. Kozyrskyj, PhD, and Allan B. Becker, MD, FRCPC
the objective of this study was to determine the risk of peanut allergy in siblings of   peanut-  allergic children. in 2005–2006, 560 
households of children born in 1995 in the province of Manitoba, canada, were surveyed. the index children (8-   to 10-  year-  olds) were 
assessed by a pediatric allergist and had skin-  prick testing and  /  or capraSt for peanut allergy. Surveys were completed by parents 
for siblings to determine the presence of peanut allergy. Of 560 surveys, 514 (92%) were completed.   twenty-  nine (5.6%) index children 
were peanut allergic. Fifteen of 900 (1.7%) siblings had peanut allergy. Four of 47 (8.5%) were siblings of   peanut-  allergic children and 
11 of 853 (1.3%) were siblings of non–peanut-  allergic children. the risk of peanut allergy was markedly increased in siblings of a 
  peanut-  allergic child (odds ratio 6.72, 95% confidence interval 2.04–22.12). Siblings of   peanut-  allergic children are much more likely 
to be allergic to peanut. an allergy assessment by a qualified allergist should be routinely recommended before feeding peanut to 
these children.
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parents ask is whether there is an increased risk of a sibling 
also developing a life-  threatening allergy to peanut.
Traditionally, allergists do not perform testing to foods be-
fore an individual has had an apparent adverse reaction to that 
food. The reason stems from the risk of finding sensitization 
to a food (ie, evidence of the presence of   allergen-  specific IgE) 
but not necessarily “allergy” (ie, having a systemic reaction). 
Routine “panel testing” to foods is not recommended by the 
American Academy of Allergy, Asthma and Immunology or 
the American College of Allergy, Asthma and Immunology. 
The rate of asymptomatic sensitization to foods in the general 
population can be as high as 30 to 50%, yet these individuals 
are not truly allergic.11
–13
We sought to determine whether there is an increased risk 
for a   peanut-  allergic child to have a sibling with a peanut al-
lergy. We asked whether an allergy assessment by a qualified 
allergist of a younger sibling of a   peanut-  allergic child might 
be a prudent approach prior to that child’s first anticipated 
exposure to peanut.
Methods
The SAGE (Study of Asthma, Genes and the Environment) 
project is a case-  control cohort study focused on the 1995 
Manitoba Birth Cohort. Approximately 14,000 children were 
born in the province of Manitoba, Canada, and still living in 
the province in 2002. In 2001–2002, a child health and home 
environment questionnaire was sent to each household. It 
  contained questions regarding the presence of asthma, food 
T
here has been a dramatic increase in food allergy and 
other atopic conditions over the past decade or more,1,2 
with the prevalence of peanut allergy increasing from 0.5%3 
a decade ago to between 1.0 and 1.8%.4
–6 Peanut allergy is 
the most common cause of fatal and near-  fatal food-  related 
anaphylaxis.7
–9 Parents with a   peanut-  allergic child often have 
a great deal of stress in attempting to ensure a   peanut-  free 
environment in the home, school, and play environments to 
prevent a life-  threatening reaction.10 A common question 
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Based on the questionnaire, diagnoses of peanut allergy 
were made as follows: parental report that the sibling has pea-
nut allergy and that the child was assessed as peanut allergic 
by a   board-  certified allergist in the province of Manitoba in 
the past 5 years (10 allergists practiced in the province dur-
ing that time), and the child currently carries an epinephrine 
auto-  injector. The allergists of those siblings were contacted 
to confirm the diagnosis of true peanut allergy; however, this 
was not a requirement for diagnosis.
The study was approved by the Health Research Ethics 
Board at the University of Manitoba and the Health Informa-
tion Privacy Committee of Manitoba.
Statistical Analysis
Statistical analysis was performed with SAS software (SAS In-
stitute, Cary, NC). Odds ratios with 95% confidence intervals 
(CIs) were calculated to determine the risk of a sibling of a 
  peanut-  allergic child having a peanut allergy when compared 
with the sibling of a non–peanut-  allergic child. Children who 
were sensitized to peanut but not clinically allergic were ex-
cluded from analysis. Stratification by older versus younger 
sibling was performed. Multivariate analysis was performed 
to adjust for parental history of asthma. In the younger sib-
ling stratification, adjustments were made for a physician 
diagnosis of asthma in the index child and parental history 
of asthma.
Results
From the SAGE case-  control cohort, 560 of 603 children tested 
to peanut were contacted to fill out the Sibling Food Allergy 
survey. Forty-  three families had completed the primary study 
before this survey was introduced. Of 560 index families, 514 
(92%) completed the survey.   Twenty-  nine (5.6%) index chil-
dren were defined as   peanut-  allergic (cases), and eight index 
children were sensitized but not allergic. Four hundred fifty 
index children were not peanut allergic or sensitized (con-
trols). The demographics of the cases and controls are shown 
in Table 1. Table 2 shows the supporting test results to confirm 
  peanut-  allergic diagnoses in index children. 
Of the 514 index children, 27 did not have siblings. There 
were 900 siblings of the index children (excluding siblings of 
children who were sensitized to peanut but not allergic). Fif-
teen (1.7%) siblings had peanut allergy: 4 of 47 (8.5%) in the 
case group and 11 of 853 (1.3%) in the control group. Table 3 
shows the evidence of peanut allergy in the siblings. We were 
able to confirm the diagnosis of peanut allergy in 14 of the 
siblings.
Eight  (1.5%)  children  were  sensitized  to  peanut  by 
allergy, and other atopic conditions in the child. From the 3,615 
returned surveys during 2003–2005, we assembled an asthma   
case-  control cohort of 723 children (now aged 8–10 years).
In addition to a focus on asthma, a pediatric allergist (J.L. 
or A.B.) assessed the children for food allergy. With respect to 
food allergy, the clinical history included questions regarding 
the type of food identified, timeline of the reaction, symptoms 
of the reaction (eg, hives, cough, wheeze, diarrhea, vomit, loss 
of consciousness), severity of the reaction, and management 
of the reaction (ie, emergency room visit, antihistamines, epi-
nephrine). The pediatric allergist clinical assessment for pea-
nut allergy was blinded to skin testing and capRast results.
Skin testing to peanut (epicutaneous method) was per-
formed on 603 children. Children sensitized to peanut had 
blood drawn for measurement of   peanut-  specific IgE by fluoren  - 
zymeimmunoassay (FEIA), generally known as capRAST. In 
consideration of the child’s history (ie, severity of the initial 
reaction, presence of eczema or asthma), if the capRAST was 
sufficiently low (≤ 2.0 kUa /   L), an oral food challenge was of-
fered to determine true allergic status.14
Index Cases of Peanut Allergy
From among the children in the nested asthma case-  control 
cohort (SAGE), a pediatric allergist diagnosed peanut allergy 
with current evidence of   peanut-  specific IgE (in vitro or in 
vivo) and / or failed peanut challenge for those children with 
low levels of   peanut-  specific IgE as noted above.
Sensitized but Not Peanut Allergic
From among the children in the cohort, the child is skin test 
positive to peanut but able to tolerate peanut without an al-
lergic reaction.
Index Controls (No Peanut Allergy)
The child eats peanut products and is skin test negative.
Assessment of Siblings
After assessment of index children, a survey was distributed 
to the parents of both cases and controls. This survey asked 
the following questions with regard to the index child’s sib-
lings: (1) Do your child’s siblings have any food allergies? 
(please name the food). If yes, (i) Was he /   she diagnosed by 
an allergist? (What is the allergist’s name?); (ii) Was he /   she 
skin tested to that food? (iii) Was a blood test sent for that 
food? (capRAST); (iv) Does he /   she carry an epinephrine 
auto-  injector (EpiPen or Twinject)?146  Allergy, Asthma, and Clinical Immunology, Volume 4, Number 4, 2008
lergy is 6.31 (95% CI 1.20–33.23). If the index child had peanut 
allergy, the adjusted odds ratio of a younger sibling also hav-
ing peanut allergy is 11.76 (95% CI 2.46–56.27).
Discussion
Using a cohort study, we have shown that the sibling of a 
  peanut-  allergic child has a dramatically increased risk of de-
veloping peanut allergy. This risk is nearly 7-  fold greater than 
those who do not have a sibling with peanut allergy, with 
skin-  prick test but not allergic (able to eat peanuts without 
an adverse reaction). None of their siblings had a peanut   
allergy.
The odds ratio of a current   peanut-  allergic child at the 
age of 9 to 10 years having a sibling also with a peanut al-
lergy is 7.12 (95% CI 2.18–23.28). After adjusting for a parental 
history of asthma, the odds ratio is 6.72 (95% CI 2.04–22.12) 
(Table 4). 
If an older sibling of the index child had peanut allergy, 
the adjusted odds ratio of the index child having a peanut al-
Table 1. Demographics of Peanut and Non–Peanut-  Allergic Children
Index Children Peanut Allergic Non–Peanut Allergic Sensitized No Siblings
Number 29 450 8 27
Male:female 16:13 248:202 5:3 18:9
Urban:rural:FN 20:8:1 247:160:43 0:6:2 18:9:0
Parental history of asthma 12 150 6 8
Total number of siblings 
(older:younger)
47 (29:18) 853 (485:368) 9 (4:5) —
FN = First Nations.
Table 2. Diagnoses of Peanut Allergy in Index Children (Cases) 
Case
Peanut Skin-  Prick Test Mean 
Wheal Diameter (mm)
Peanut-  Specific 
IgE (kUa /   L)




1 NA 81.1 NA No
2 NA 5.2 NA No
3 NA 42.8 NA No
4 13 > 100 NA No
5 NA > 100 NA No
6 10 > 100 NA Yes
7 9 > 100 NA Yes
8 0 > 100 NA No
9 7 > 100 NA Yes
10 0 1 Failed oral challenge† No
11 5 5.7 NA No
12 6 1.1 Refused oral challenge No
13 4 16.9 NA No
14 5 > 100 NA No
15 10 29 NA No
16 9 41 NA No
17 11 > 100 NA Yes
18 10 1.4 Offered but lost to   follow-  up No
19 7 0.8 Failed oral challenge† No
20 8 2.09 NA No
21 17 NA NA No
22 10 > 100 NA No
23 8 0.72 Failed oral challenge† No
24 15 80.2 NA No
25 7 > 100 NA No
26 8 17.6 NA No
27 6 < 0.35 Lost to   follow-  up No
28 8 28.2 NA No
29 10 36.7 NA No
NA = not available.
*In general, oral food challenges to peanut were offered to those with a capRast < 2.0 kUa /   L.14
All children had a convincing history of peanut allergy prior to performing skin-  prick testing ± capRAST.
†An oral challenge to peanut was performed in the hospital and the child had an adverse reaction.  Liem et al, Siblings of   Peanut-  Allergic Children Should Have an Allergy Assessment  147
Hourihane and colleagues examined the rates of atopic 
manifestations in people with peanut allergy and the preva-
lence of such allergy in their families by surveying 622 adults 
and children with reported, suspected, or known peanut al-
lergy.16 They evaluated 50 local children (mean age 5 years) 
with apparent peanut allergy and compared their results with 
those of a general population prevalence of peanut allergy 
(1.0–1.5%). In that study, the prevalence of peanut allergy in 
siblings of a   peanut-  allergic child was 7% (3 of 39). Sicherer 
and colleagues evaluated 58 twin pairs (median age of 5 years) 
ascertained through the Food Allergy Network.17 They found 
a 64.3% pairwise concordance between monozygotic pairs 
and 6.8% concordance between dizygotic pairs. Our preva-
lence of 8.5% (4 of 47) among siblings is quite similar to both 
studies. Our study differs with the above two in that we stud-
ied a birth cohort of children all born in 1995 from across the 
province of Manitoba.
When we stratify our sibling cohort into younger and 
older siblings, we demonstrate that the younger sibling par-
ticularly has a very highly statistically significant increased 
risk for having a peanut allergy. Clearly, there is a genetic 
predisposition for peanut allergy in these families. Given the 
greater likelihood for a younger sibling having peanut allergy, 
we also question how much of a role the environment may 
play. As far as we are aware, there are no studies examin-
ing the impact of parental behaviour change with having a 
  peanut-  allergic child in the family. Intuitively, we would ex-
pect that parents will alter their behaviour to decrease expo-
sure to peanut (ie, avoidance of peanut and tree nuts), particu-
larly in the home environment. Of concern, recent human and 
animal literature suggests that avoidance of highly “allergenic” 
foods in pregnancy and early in life may actually predispose, 
as opposed to protect, a child to develop IgE-  mediated food   
allergy.18
–20
Another finding from our study is the fact that 22% of 
children with positive skin testing to peanut (8 of 37 children) 
routinely had peanut without a problem. That is, these chil-
dren were sensitized, but not truly allergic. This confirms other 
studies that have shown that a positive skin-  prick test is only 
“suggestive” of the presence of a clinical peanut allergy.11
–13 A 
diagnosis of peanut allergy cannot be solely based on a skin-
  prick test but requires a proper clinical history or additional 
testing to corroborate the presence of true allergy. Although 
we agree that indiscriminate testing for peanut allergy should 
not be performed, based on our findings in this study, we rec-
ommend that siblings of   peanut-  allergic children should be 
assessed by a qualified allergist and, potentially, have appro-
priate skin testing.
Of note, two children in our cohort diagnosed by the pedi-
atric allergist as allergic to peanut were skin test negative. One 
an almost 12-  fold increased risk for peanut allergy among 
younger siblings.
Emmett and colleagues examined the perceived preva-
lence of peanut allergy in Great Britain by using a screening 
survey followed by in-  depth interviews with all reported suf-
ferers from peanut allergy.15 They estimated a peanut preva-
lence of 0.48%. Given one case in a household, the probability 
of another was estimated at 3.2%—six times that in the United 
Kingdom (p < .001). Nine of the 10 second cases in the same 
household were in   first-  degree relatives. They do not specify 
if these relatives were siblings. Our sevenfold increased risk is 
similar to their findings, except specifically for siblings.








Evidence of IgE SPT or 
capRast 
Cases
1 6 Yes capRast > 100 kUa /   L
2 7 Yes capRast > 100 kUa /   L
3 9 Yes capRast > 100 kUa /   L
4 17 Yes SPT mean wheal diameter 
21 mm
Controls
1 NA Yes SPT mean wheal diameter 
21 mm
2 NA Yes capRast > 100 kUa /   L
3 NA Yes Large SPT+ (no 
measurement recorded)
4 NA Yes SPT mean wheal diameter 
8 mm 
5 NA Yes capRast = 90.3 kUa /   L
6 NA Yes capRast = 22.8 kUa /   L
7 NA Yes SPT mean wheal diameter 
14 mm
8 NA Yes SPT: 4+ reaction 
(pseudopods)
9 NA No Not confirmed
10 NA Yes capRast > 100 kUa /   L
11 NA Yes capRast = 2.3 kUa /   L; no oral 
challenge 
capRAST = FEIA for peanut-specific IgE; NA = not available; SPT = skin-  prick test.
*Allergist diagnosis included a definitive history of an adverse reaction to ingestion of 
peanut and evidence (in vivo or in vitro) of IgE toward peanut. Only control 9 was not 
confirmed.
Table 4. Risk of Peanut Allergy in Siblings of a   Peanut-  Allergic Child
Risk of Peanut 
Allergy in
Unadjusted 




Any sibling  7.12 2.18–23.28 6.72* 2.04–22.12
Younger sibling† 9.08 1.63–50.40 11.76‡ 2.46–56.27
Older sibling§ 5.92 1.14–30.69 6.31* 1.20–33.23
CI = confidence interval.
*Adjusted for parental history of asthma.
†If index child had a peanut allergy, risk of peanut allergy in a younger sibling.
‡Adjusted for parental history of asthma and physician diagnosis of asthma in index child.
§If older sibling had a peanut allergy, risk of peanut allergy in the index child.148  Allergy, Asthma, and Clinical Immunology, Volume 4, Number 4, 2008
In summary, we have shown that siblings of   peanut-   
allergic children have a significantly increased risk of also 
developing a peanut allergy. We recommend that siblings 
born into a family with a   peanut-  allergic child be assessed 
for peanut allergy by a qualified allergist (who may perform 
skin-  prick testing or measurement of   allergen-  specific IgE by 
capRAST or other technique) prior to being fed this food. An 
oral challenge in a controlled setting may be required. Future 
research must examine gene–environment interactions pre-
disposing children to this increasingly common and poten-
tially fatal food allergy.
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